Inhibitex Inc. (INHX) surged 98 percent, the most in the Russell 2000 Index, to $7.82. The biopharmaceutical company reported a slighter third-quarter loss than analysts estimated and said a clinical test of an elevated quantity of INX-189, an oral treatment for chronic hepatitis C, illustrated no serious adverse events.
Jefferies Group Inc. (JEF) reported the fall of 6.2 percent to $11.27. The investment bank faces a huge evacuation of hedge fund clients that use its prime brokerage services that may lead to a probable liquidity crunch, citing people in the major brokerage units at three competing banks. Jefferies spokesman Richard Khaleel said the prime brokerage business is not part of our firm financial support government.
LinkedIn Corp. (LNKD US) slid 10 percent to $78.78 and rubbed out 11 percent previously, the most intraday since Aug. 8. The largest professional-networking website, reported a third- quarter loss of $1.6 million as the company increased spending on research and development.
MasTec Inc. (MTZ) slipped 19 percent to $17.69 after declining as much as 28 percent, the most intraday since November 2007. The contractor said it expects fourth-quarter earnings excluding some items of at most 15 cents a share, mislaid the average analyst estimation of 35 cents.
MedAssets Inc. (MDAS) jumped 23 percent to $12.69 and rallied 26 percent earlier, the most intraday since December 2007. The supplier of information technology services to health- care companies reported third-quarter sales and profits that were more than analysts�� estimates.
No comments:
Post a Comment